Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061.
Eric Van CutsemMayur AmonkarCharles S FuchsMaria AlsinaMustafa ÖzgüroğluYung-Jue BangHyun Cheol ChungKei MuroEray GoekkurtAl B BensonWeijing SunZev A WainbergJosephine M NorquistXinqun ChenChie-Schin ShihKohei ShitaraPublished in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2021)
ClinicalTrials.gov, NCT02370498.